Several studies have also demonstrated that ADAMTS1 is downregulated in breast cancer, prostate cancer, lung cancer, pancreatic cancer and colorectal cancer (18–20,25,27,28). This evidence concerns the gene ADAMTS1 and lung carcinoma.